RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
RenovoRx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.16+0.02 (+1.75%)
Close on Oct 19, 2026
- Market cap
- $54.87M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
RenovoRx has not reported a dividend
No dividend per share appears in RenovoRx's annual filings since fiscal 2019.